TYMS and cancer: Many clinical studies on human cancers, including NSCLCs and gastrointestinal tumours, have shown that high TS expression is associated with 5-FU resistance and a poor outcome (Johnston et al, 1995; Yeh et al, 1998; Huang et al, 2000).